CARDIAC POSITRON EMISSION TOMOGRAPHY - THE FOUNDATIONS AND CLINICAL-APPLICATIONS

被引：4

作者：

CHAN, SY

BRUNKEN, RC

BUXTON, DB

机构：

[1] Division of Nuclear Medicine and Biophysics, Department of Radiological Sciences, Laboratory of Nuclear Medicine, University of California, UCLA School of Medicine, Laboratory of Biomedical and Environmental Sciences, Los Angeles, CA

[2] Division of Nuclear Medicine and Biophysics, Department of Radiological Sciences, UCLA School of Medicine, Los Angeles, CA

来源：

JOURNAL OF THORACIC IMAGING | 1990年 / 5卷 / 03期

关键词：

D O I：

10.1097/00005382-199007000-00005

中图分类号：

R8 [特种医学]; R445 [影像诊断学];

学科分类号：

1002 ; 100207 ; 1009 ;

摘要：

Cardiac PET studies may have a role in the early detection of coronary artery disease. The early prediction of the ultimate fate of reperfused myocardium with cardiac PET imaging remains elusive. At present the predominant clinical use of PET scans lies in the identification of ischemic but viable tissue. Cardiac PET imaging with a combination of perfusion and metabolic tracers can distinguish those patients with a history of previous infarctions and severe heart failure who will benefit from therapeutic revascularization. Conversely, the group that is not expected to improve will be spared needless and risky attempts at revascularization and will become candidates for cardiac transplantation at an earlier stage. © 1990 Aspen Publishers, Inc.

引用

页码：9 / 19

页数：11

共 88 条

[81] Tillisch J., Brunken R., Marshall R., Et al., Reversibility of cardiac wall-motion abnormalities predicted by positron tomography, N Engl J Med, 314, pp. 884-888, (1986)
[82] Brunken R.C., Tillisch J., Schwaiger M., Et al., Regional perfusion, glucose metabolism, and wall motion in patients with chronic electrocardiographic Q wave infarction: Evidence for persistence of viable tissue in some infarct regions by positron emission tomography, Circulation, 73, 5, pp. 951-963, (1986)
[83] Brunken R.C., Schwaiger M., Grover-McKay M., Phelps M.E., Tillisch J., Scbelbert H.R., Positron emission tomography detects tissue metabolic activity in myocardial segments with persistent thallium perfusion defects, J Am Coll Cardiol, 10, 3, pp. 557-567, (1987)
[84] Brunken R.C., Kottou S., Nienaber C.A., Et al., PET detection of viable tissue in myocardial segments with persistent defects at T1-201 SPECT, Radiology, 172, 1, pp. 65-73, (1989)
[85] Brunken R.C., Kottou S., Nienaber C.A., Et al., Tissue glucose metabolism detected with PET in myocardial segments with persistent SPECT thallium defects, J Nucl Med, 29, (1988)
[86] Bonow R.O., Bacharach S.L., Cuocolo A., Dilsizian V., Myocardial viability in coronary artery disease and left ventricular dysfunction: Thallium-201 reinjection vs fluorodeoxyglucose, Circulation, 80, (1989)
[87] Dilsizian V., Swain J., Dextras R., Almagor Y.f., Bonow R., Prediction of viable myocardium by thallium reinjection at rest after stress-redistribution imaging: A pre- and post-revascularization study, Circulation, 80, (1989)
[88] Kayden D.S., Sigal S.L., Soufer R., Zaret B.L., Wackers F.J., 24 hour planar thallium-201 delayed imaging: Is reinjection necessary?, Circulation, 80, (1989)

← 1 2 3 4 5 6 7 8 9 →